Does anti-VEGF bevacizumab improve survival in experimental sepsis?

被引：13

作者：

Besnier, Emmanuel ^{[1
,2
]}

Brakenhielm, Ebba ^{[1
]}

Richard, Vincent ^{[1
]}

Tamion, Fabienne ^{[1
,3
]}

机构：

[1] Normandie Univ, UNIROUEN, INSERM, U1096, F-76000 Rouen, France

[2] Rouen Univ Hosp, Dept Anaesthesia & Crit Care, F-76000 Rouen, France

[3] Rouen Univ Hosp, Med Crit Care Unit, F-76000 Rouen, France

来源：

CRITICAL CARE | 2017年 / 21卷

关键词：

ENDOTHELIAL GROWTH-FACTOR;

D O I：

10.1186/s13054-017-1734-x

中图分类号：

R4 [临床医学];

学科分类号：

1002 ; 100602 ;

摘要：

引用

收藏

页数：2

相关论文

共 4 条

[1] Anti-vascular endothelial growth factor antibody attenuates inflammation and decreases mortality in an experimental model of severe sepsis
Jeong, Su Jin
Han, Sang Hoon
Kim, Chang Oh
Choi, Jun Yong
Kim, June Myung
[J]. CRITICAL CARE, 2013, 17 (03):
[2] A prospective, observational study of soluble FLT-1 and vascular endothelial growth factor in sepsis
Shapiro, Nathan I.
Yano, Kiichiro
Okada, Hitomi
Fischer, Christopher
Howell, Michael
Spokes, Katherine C.
Ngo, Long
Angus, Derek C.
Aird, William C.
[J]. SHOCK, 2008, 29 (04): : 452 - 457
[3] Toscano MG, 2011, JOVE-J VIS EXP, V51, P2860, DOI DOI 10.3791/2860
[4] Soluble vascular endothelial growth factor receptor-1 protects mice in sepsis
Tsao, Po-Nien
Chan, Feng-Tsan
Wei, Shu-Chen
Hsieh, Wu-Shiun
Chou, Hung-Chieh
Su, Yi-Ning
Chen, Chien-Yi
Hsu, Wen-Ming
Hsieh, Fon-Jou
Hsu, Su-Ming
[J]. CRITICAL CARE MEDICINE, 2007, 35 (08) : 1955 - 1960